| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 2.27e-10 | 43 | 125 | 8 | GO:0030280 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.35e-06 | 127 | 125 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | RAD51D ABCA4 DNAH10 MYO9B SMCHD1 INO80 XRCC5 SUPV3L1 MCM9 NAV2 RAD17 | 1.04e-04 | 441 | 125 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51D ABCA4 DNAH10 MYO9A MYO9B SMCHD1 INO80 XRCC5 BPTF SUPV3L1 MCM9 NAV2 RAD17 | 1.27e-04 | 614 | 125 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.48e-04 | 262 | 125 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 SRBD1 FLG2 THBS2 KRT76 EFEMP1 KRT6C TUBGCP3 POM121B MUC4 | 4.58e-04 | 891 | 125 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | DNA helicase activity | 6.17e-04 | 62 | 125 | 4 | GO:0003678 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.10e-08 | 75 | 128 | 8 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinization | 6.84e-08 | 87 | 128 | 8 | GO:0031424 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.88e-07 | 99 | 128 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 2.04e-07 | 100 | 128 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.81e-06 | 189 | 128 | 9 | GO:0030216 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAM TRO ITGA4 WNK1 FAT2 NECTIN2 PCDH1 PCDH8 SDK1 PALLD ADGRL3 | 4.15e-06 | 313 | 128 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | retina layer formation | 1.62e-05 | 25 | 128 | 4 | GO:0010842 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.22e-05 | 187 | 128 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 7.15e-05 | 284 | 128 | 9 | GO:0009913 | |
| GeneOntologyBiologicalProcess | skin development | 1.13e-04 | 373 | 128 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | cytosolic small ribosomal subunit assembly | 1.14e-04 | 3 | 128 | 2 | GO:0180025 | |
| GeneOntologyBiologicalProcess | small-subunit processome assembly | 1.14e-04 | 3 | 128 | 2 | GO:0034462 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | IGLV3-32 IGLV3-27 IGLV3-25 IGLV3-16 IGLV2-14 IGLV2-11 IGLV2-8 PRKDC | 1.33e-04 | 241 | 128 | 8 | GO:0002377 |
| GeneOntologyBiologicalProcess | epidermis development | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 FLG2 TFDP1 KRT76 KRT6C PALLD | 1.44e-04 | 461 | 128 | 11 | GO:0008544 |
| GeneOntologyBiologicalProcess | epithelium development | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 MYO9A CASR ITGA4 FLG2 RFX3 FREM2 KRT76 SLC12A2 KRT6C CD44 DUSP10 PRKDC PCDH8 PALLD MRTFA | 2.72e-04 | 1469 | 128 | 21 | GO:0060429 |
| GeneOntologyCellularComponent | keratin filament | 1.45e-07 | 97 | 128 | 8 | GO:0045095 | |
| GeneOntologyCellularComponent | Golgi lumen | 4.86e-06 | 109 | 128 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.57e-05 | 263 | 128 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.25e-05 | 269 | 128 | 9 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 7.01e-05 | 287 | 128 | 9 | GO:0035770 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGLV3-32 IGLV3-27 IGLV3-25 IGLV3-16 IGLV2-14 IGLV2-11 IGLV2-8 | 7.41e-05 | 166 | 128 | 7 | GO:0019814 |
| GeneOntologyCellularComponent | intermediate filament | 7.99e-05 | 227 | 128 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 1.07e-04 | 176 | 128 | 7 | GO:0000781 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 3.12e-04 | 96 | 128 | 5 | GO:0010494 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 3.68e-04 | 5 | 128 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 DNAH10 MYO9A MYO9B CHMP1B INO80 KRT76 KRT6C TUBGCP3 PALLD | 4.03e-04 | 899 | 128 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RAD51D CHMP1B LIN54 SUN1 HIPK2 INO80 XRCC5 SARNP TFDP1 BPTF GTF2F2 UBAP2L NFRKB KMT2A DGCR8 PRKDC POM121B SAP130 HCFC1 | 7.17e-04 | 1377 | 128 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | DNA-dependent protein kinase-DNA ligase 4 complex | 7.66e-04 | 7 | 128 | 2 | GO:0005958 | |
| GeneOntologyCellularComponent | cornified envelope | 8.52e-04 | 69 | 128 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | Barr body | 1.02e-03 | 8 | 128 | 2 | GO:0001740 | |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 1.30e-03 | 9 | 128 | 2 | GO:0070419 | |
| HumanPheno | Palmoplantar blistering | 2.18e-06 | 11 | 48 | 4 | HP:0007446 | |
| Domain | Keratin_II | 3.25e-12 | 26 | 120 | 8 | IPR003054 | |
| Domain | Keratin_2_head | 1.20e-10 | 24 | 120 | 7 | IPR032444 | |
| Domain | Keratin_2_head | 1.20e-10 | 24 | 120 | 7 | PF16208 | |
| Domain | Intermediate_filament_CS | 6.61e-09 | 63 | 120 | 8 | IPR018039 | |
| Domain | IF | 1.95e-08 | 72 | 120 | 8 | PS00226 | |
| Domain | Filament | 2.18e-08 | 73 | 120 | 8 | PF00038 | |
| Domain | IF | 3.00e-08 | 76 | 120 | 8 | IPR001664 | |
| Domain | Filament | 3.59e-07 | 71 | 120 | 7 | SM01391 | |
| Domain | SPOC_C | 5.10e-06 | 6 | 120 | 3 | IPR012921 | |
| Domain | SPOC | 5.10e-06 | 6 | 120 | 3 | PF07744 | |
| Domain | AAA | 3.36e-04 | 144 | 120 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 3.36e-04 | 144 | 120 | 6 | IPR003593 | |
| Domain | SEA | 3.64e-04 | 22 | 120 | 3 | PF01390 | |
| Domain | - | 4.04e-04 | 5 | 120 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 4.04e-04 | 5 | 120 | 2 | IPR016194 | |
| Domain | FATC | 4.04e-04 | 5 | 120 | 2 | PF02260 | |
| Domain | SEA | 4.17e-04 | 23 | 120 | 3 | PS50024 | |
| Domain | SEA_dom | 4.17e-04 | 23 | 120 | 3 | IPR000082 | |
| Domain | FAT | 6.04e-04 | 6 | 120 | 2 | PS51189 | |
| Domain | FATC | 6.04e-04 | 6 | 120 | 2 | PS51190 | |
| Domain | FATC_dom | 6.04e-04 | 6 | 120 | 2 | IPR003152 | |
| Domain | PIK_FAT | 6.04e-04 | 6 | 120 | 2 | IPR014009 | |
| Domain | FATC | 6.04e-04 | 6 | 120 | 2 | SM01343 | |
| Domain | TFS2M | 8.42e-04 | 7 | 120 | 2 | SM00510 | |
| Domain | ApoL | 8.42e-04 | 7 | 120 | 2 | PF05461 | |
| Domain | ApoL | 8.42e-04 | 7 | 120 | 2 | IPR008405 | |
| Domain | TFIIS_M | 8.42e-04 | 7 | 120 | 2 | PF07500 | |
| Domain | UBA | 9.25e-04 | 30 | 120 | 3 | SM00165 | |
| Domain | Cadherin | 9.88e-04 | 118 | 120 | 5 | IPR002126 | |
| Domain | TFIIS_cen_dom | 1.12e-03 | 8 | 120 | 2 | IPR003618 | |
| Domain | DUF1669 | 1.12e-03 | 8 | 120 | 2 | PF07894 | |
| Domain | DUF1669 | 1.12e-03 | 8 | 120 | 2 | IPR012461 | |
| Domain | Calx_beta | 1.12e-03 | 8 | 120 | 2 | SM00237 | |
| Domain | - | 1.12e-03 | 8 | 120 | 2 | 1.10.472.30 | |
| Domain | TFIIS_CENTRAL | 1.12e-03 | 8 | 120 | 2 | PS51321 | |
| Domain | PHD | 1.39e-03 | 75 | 120 | 4 | PF00628 | |
| Domain | Calx_beta | 1.43e-03 | 9 | 120 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.43e-03 | 9 | 120 | 2 | PF03160 | |
| Domain | UBA | 1.58e-03 | 36 | 120 | 3 | PF00627 | |
| Domain | Znf_PHD-finger | 1.68e-03 | 79 | 120 | 4 | IPR019787 | |
| Domain | BROMODOMAIN_2 | 2.31e-03 | 41 | 120 | 3 | PS50014 | |
| Domain | Bromodomain | 2.47e-03 | 42 | 120 | 3 | IPR001487 | |
| Domain | BROMO | 2.47e-03 | 42 | 120 | 3 | SM00297 | |
| Domain | - | 2.47e-03 | 42 | 120 | 3 | 1.20.920.10 | |
| Domain | GrpE_coiled_coil | 2.59e-03 | 12 | 120 | 2 | IPR013805 | |
| Domain | PHD | 2.60e-03 | 89 | 120 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.82e-03 | 91 | 120 | 4 | IPR001965 | |
| Domain | Keratin_I | 2.83e-03 | 44 | 120 | 3 | IPR002957 | |
| Domain | UBA | 2.83e-03 | 44 | 120 | 3 | IPR015940 | |
| Domain | Kelch_2 | 3.05e-03 | 13 | 120 | 2 | IPR011498 | |
| Domain | Kelch_2 | 3.05e-03 | 13 | 120 | 2 | PF07646 | |
| Domain | - | 3.29e-03 | 95 | 120 | 4 | 2.60.120.200 | |
| Domain | ZF_PHD_2 | 3.29e-03 | 95 | 120 | 4 | PS50016 | |
| Domain | UBA | 3.41e-03 | 47 | 120 | 3 | PS50030 | |
| Domain | ZF_PHD_1 | 3.42e-03 | 96 | 120 | 4 | PS01359 | |
| Domain | SEA | 3.54e-03 | 14 | 120 | 2 | SM00200 | |
| Domain | CUB | 3.84e-03 | 49 | 120 | 3 | PF00431 | |
| Domain | CUB | 4.07e-03 | 50 | 120 | 3 | SM00042 | |
| Domain | - | 4.07e-03 | 15 | 120 | 2 | 3.30.70.960 | |
| Domain | PI3/4_kinase_CS | 4.07e-03 | 15 | 120 | 2 | IPR018936 | |
| Domain | - | 4.55e-03 | 52 | 120 | 3 | 2.60.120.290 | |
| Domain | VWF_type-D | 4.63e-03 | 16 | 120 | 2 | IPR001846 | |
| Domain | - | 4.63e-03 | 16 | 120 | 2 | 1.10.1070.11 | |
| Domain | VWFD | 4.63e-03 | 16 | 120 | 2 | PS51233 | |
| Domain | PI3Kc | 4.63e-03 | 16 | 120 | 2 | SM00146 | |
| Domain | VWD | 4.63e-03 | 16 | 120 | 2 | SM00216 | |
| Domain | VWD | 4.63e-03 | 16 | 120 | 2 | PF00094 | |
| Domain | CUB | 4.80e-03 | 53 | 120 | 3 | PS01180 | |
| Domain | PI3_PI4_kinase | 5.86e-03 | 18 | 120 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.86e-03 | 18 | 120 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.86e-03 | 18 | 120 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.86e-03 | 18 | 120 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.86e-03 | 18 | 120 | 2 | PS50290 | |
| Domain | CUB_dom | 5.88e-03 | 57 | 120 | 3 | IPR000859 | |
| Domain | EGF_1 | 6.12e-03 | 255 | 120 | 6 | PS00022 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.88e-08 | 16 | 94 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 6.88e-08 | 17 | 94 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.21e-07 | 21 | 94 | 5 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.62e-07 | 23 | 94 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 6.97e-07 | 26 | 94 | 5 | M27483 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.77e-06 | 87 | 94 | 7 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.28e-06 | 129 | 94 | 8 | M27649 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.87e-06 | 68 | 94 | 6 | M27303 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 6.40e-06 | 69 | 94 | 6 | M27150 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 4.81e-05 | 98 | 94 | 6 | M27152 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.84e-05 | 60 | 94 | 5 | MM15636 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 5.25e-05 | 61 | 94 | 5 | M27581 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.68e-05 | 62 | 94 | 5 | M546 | |
| Pathway | REACTOME_KERATINIZATION | 7.19e-05 | 153 | 94 | 7 | MM15343 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 8.73e-05 | 109 | 94 | 6 | MM15164 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 9.50e-05 | 69 | 94 | 5 | M27108 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.65e-05 | 111 | 94 | 6 | M27416 | |
| Pathway | REACTOME_KERATINIZATION | 9.91e-05 | 217 | 94 | 8 | M27640 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 1.09e-04 | 71 | 94 | 5 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 1.09e-04 | 71 | 94 | 5 | M27203 | |
| Pathway | REACTOME_PARASITE_INFECTION | 1.23e-04 | 116 | 94 | 6 | M29843 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.92e-04 | 80 | 94 | 5 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 2.16e-04 | 82 | 94 | 5 | M27110 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 2.69e-04 | 86 | 94 | 5 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 2.69e-04 | 86 | 94 | 5 | M27206 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.76e-04 | 190 | 94 | 7 | M8240 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 2.84e-04 | 87 | 94 | 5 | M27205 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 3.13e-04 | 194 | 94 | 7 | M16312 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.84e-04 | 143 | 94 | 6 | M27107 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.84e-04 | 143 | 94 | 6 | M27275 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 4.28e-04 | 95 | 94 | 5 | M29842 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | PLXNA3 KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 DSCAM MYO9B KRT76 USF1 | 5.00e-04 | 502 | 94 | 11 | MM14537 |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 5.69e-04 | 154 | 94 | 6 | M39007 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 9.04e-04 | 7 | 94 | 2 | MM15989 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.02e-03 | 115 | 94 | 5 | M19752 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | KRT1 MUC21 MYO9B MUC16 MUC12 HUWE1 FLG2 XRCC5 IGLV3-27 IGLV3-25 IGLV2-14 IGLV2-11 IGLV2-8 CD44 PRKDC MUC1 MUC4 | 1.16e-03 | 1128 | 94 | 17 | M1036 |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 1.54e-03 | 9 | 94 | 2 | MM1534 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 1.54e-03 | 9 | 94 | 2 | M22008 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | MUC21 MUC19 HIPK2 MUC16 INO80 APOL1 F8 THBS2 LMO7 NFRKB APOL3 EEF1AKMT2 PRKDC MUC1 POM121B MUC4 HCFC1 MRTFA PCSK9 | 1.81e-03 | 1389 | 94 | 19 | MM15307 |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 1.91e-03 | 10 | 94 | 2 | M39469 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 2.01e-03 | 134 | 94 | 5 | M29840 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.05e-03 | 38 | 94 | 3 | MM17073 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 2.14e-03 | 136 | 94 | 5 | M27207 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 2.33e-03 | 11 | 94 | 2 | MM1436 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 2.33e-03 | 11 | 94 | 2 | M4956 | |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 2.37e-03 | 40 | 94 | 3 | M48231 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.43e-03 | 140 | 94 | 5 | M27484 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.73e-03 | 42 | 94 | 3 | M48018 | |
| Pathway | KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION | 2.78e-03 | 12 | 94 | 2 | M47856 | |
| Pubmed | MYCBP2 SMCHD1 DIDO1 HUWE1 YEATS2 BPTF GTF2F2 LMO7 UBAP2L PHF3 SAP30BP NFRKB KMT2A PRKDC SPEN PCBP1 SAP130 PALLD HCFC1 | 1.92e-13 | 549 | 128 | 19 | 38280479 | |
| Pubmed | 3.83e-11 | 57 | 128 | 8 | 31862882 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CDKN2AIP SMCHD1 LIN54 DIDO1 XRCC5 SARNP YEATS2 BPTF GTF2F2 UBAP2L PHF3 SAP30BP NFRKB KMT2A DGCR8 PRKDC SPEN PCBP1 SAP130 HCFC1 YTHDF2 | 4.95e-11 | 954 | 128 | 21 | 36373674 |
| Pubmed | 8.82e-11 | 63 | 128 | 8 | 16831889 | ||
| Pubmed | KRT1 KRT5 KRT6A KRT6B KRT78 CDKN2AIP XRCC5 WNK1 TUBGCP3 CD44 LSM14A PRKDC EXOC2 | 9.07e-11 | 298 | 128 | 13 | 30737378 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SMCHD1 LIN54 DIDO1 INO80 SRBD1 XRCC5 TFDP1 BPTF GTF2F2 PHF3 NFRKB KMT2A USF1 SPEN HCFC1 LRIF1 BRWD1 | 1.09e-10 | 608 | 128 | 17 | 36089195 |
| Pubmed | LIN54 MUC19 DIDO1 TFDP1 YEATS2 GTF2F2 NFRKB KMT2A SPEN SAP130 HCFC1 LRIF1 ZNF687 | 4.41e-10 | 339 | 128 | 13 | 30415952 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | SMCHD1 LIN54 HUWE1 SRBD1 FLG2 XRCC5 TFDP1 PHF3 LSM14A PRKDC USF1 PCBP1 SAP130 HCFC1 YTHDF2 ZNF687 | 5.25e-10 | 583 | 128 | 16 | 29844126 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCBP2 DIDO1 HUWE1 ECPAS YEATS2 BPTF TBC1D10B LMO7 UBAP2L PHF3 NFRKB KMT2A PRKDC EXOC2 SPEN PCBP1 MRTFA ZNF687 | 5.69e-10 | 774 | 128 | 18 | 15302935 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | SMCHD1 DIDO1 XRCC5 SARNP BPTF GTF2F2 PHF3 SAP30BP PRKDC SPEN PCBP1 HCFC1 | 6.85e-10 | 283 | 128 | 12 | 30585729 |
| Pubmed | MYCBP2 CDKN2AIP SMCHD1 LIN54 DIDO1 ECPAS SARNP YEATS2 BPTF GTF2F2 TUBGCP3 NFRKB KMT2A LSM14A PRKDC USF1 SPEN SAP130 HCFC1 LRIF1 ZNF687 | 6.86e-10 | 1103 | 128 | 21 | 34189442 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 9.30e-10 | 84 | 128 | 8 | 29563501 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 SMCHD1 DIDO1 ITGA4 SRBD1 FLG2 XRCC5 FAM83B GTF2F2 LMO7 PHF3 SAP30BP LSM14A PRKDC SPEN PCBP1 YTHDF2 | 1.22e-09 | 1257 | 128 | 22 | 36526897 |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 1.78e-09 | 91 | 128 | 8 | 34445801 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SMCHD1 LIN54 DIDO1 INO80 SRBD1 XRCC5 RABL3 YEATS2 BPTF LMO7 PHF3 SAP30BP NFRKB KMT2A PRKDC USF1 SPEN PCBP1 SAP130 HCFC1 LRIF1 ZNF687 | 2.08e-09 | 1294 | 128 | 22 | 30804502 |
| Pubmed | SMG1 DNAH10 SMCHD1 LIN54 HIPK2 DIDO1 INO80 TNRC6C FLG2 XRCC5 TFDP1 YEATS2 BPTF UBAP2L NFRKB KMT2A LSM14A SPEN SAP130 HCFC1 LRIF1 YTHDF2 ZNF687 | 2.41e-09 | 1429 | 128 | 23 | 35140242 | |
| Pubmed | KRT6B DIDO1 SRBD1 ECPAS SARNP YEATS2 BPTF GTF2F2 PHF3 NECTIN2 CD44 SAP130 MRTFA ZNF687 | 2.52e-09 | 472 | 128 | 14 | 38943005 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 2.64e-09 | 16 | 128 | 5 | 12399393 | |
| Pubmed | KRT1 KRT5 DSCAM LIN54 MUC16 NBEA HUWE1 FLG2 RABL3 FAM83B SLC12A2 NECTIN2 CD44 DGCR8 PRKDC SPEN SDK1 | 4.42e-09 | 777 | 128 | 17 | 35844135 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | RC3H2 MYCBP2 SMCHD1 LIN54 DIDO1 INO80 TFDP1 YEATS2 BPTF NFRKB KMT2A PCBP1 HCFC1 LRIF1 | 4.62e-09 | 495 | 128 | 14 | 27705803 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.15e-09 | 18 | 128 | 5 | 18834073 | |
| Pubmed | 6.48e-09 | 107 | 128 | 8 | 32989256 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 FLG2 XRCC5 SARNP KRT6C KMT2A PRKDC SPEN PCBP1 ZNF687 | 7.37e-09 | 605 | 128 | 15 | 28977666 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | KRT78 MYCBP2 SMCHD1 DIDO1 XRCC5 OTOF LMO7 PHF3 PRKDC SPEN PCBP1 PALLD | 1.05e-08 | 361 | 128 | 12 | 26167880 |
| Pubmed | PLXNA3 KRT1 SMG1 KRT5 KRT6A KRT6B TRO SMCHD1 LIN54 SRBD1 XRCC5 TTC3 BPTF KRT76 KRT6C LMO7 SAP30BP NAV2 KMT2A LSM14A PRKDC SPEN | 1.47e-08 | 1442 | 128 | 22 | 35575683 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYCBP2 MYO9B SMCHD1 DIDO1 SRBD1 XRCC5 SARNP BPTF UBAP2L PHF3 MCM9 LSM14A DGCR8 PRKDC SAP130 YTHDF2 | 2.19e-08 | 759 | 128 | 16 | 35915203 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 LIN54 MAGEE1 FLG2 YEATS2 KRT76 KRT6C PRKDC PCBP1 | 2.37e-08 | 564 | 128 | 14 | 21565611 |
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 2.71e-08 | 49 | 128 | 6 | 8951372 | |
| Pubmed | MUC16 DIDO1 INO80 HUWE1 ECPAS XRCC5 YEATS2 BPTF TUBGCP3 PRKDC SPEN SAP130 | 2.91e-08 | 396 | 128 | 12 | 26687479 | |
| Pubmed | KRT1 KRT5 KRT6A KRT6B KRT78 FLG2 XRCC5 GTF2F2 KRT6C LMO7 PRKDC PCBP1 YTHDF2 | 3.41e-08 | 488 | 128 | 13 | 31324722 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 3.81e-08 | 134 | 128 | 8 | 25452129 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KRT1 KRT5 MYO9A MYO9B LIN54 TBC1D2B HIPK2 HUWE1 WNK1 FAM83B YEATS2 LMO7 SPEN LRIF1 | 3.98e-08 | 588 | 128 | 14 | 38580884 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT5 KRT6A KRT78 MYCBP2 MYO9B SMCHD1 SUN1 HUWE1 XRCC5 FAM83B BPTF SLC12A2 KRT6C LMO7 UBAP2L PRKDC SPEN PCBP1 | 4.30e-08 | 1024 | 128 | 18 | 24711643 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SMCHD1 DIDO1 HUWE1 XRCC5 BPTF LMO7 UBAP2L PHF3 PRKDC PALLD HCFC1 | 4.58e-08 | 332 | 128 | 11 | 32786267 |
| Pubmed | DIDO1 HUWE1 WNK1 LMO7 UBAP2L PHF3 NAV2 SPEN PCBP1 PALLD HCFC1 MRTFA ZNF687 | 4.85e-08 | 503 | 128 | 13 | 16964243 | |
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 23053434 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 29357356 | ||
| Pubmed | Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. | 4.87e-08 | 3 | 128 | 3 | 12893366 | |
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 29587848 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 27483328 | ||
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 24939955 | ||
| Pubmed | Expression of mucin (MUC) genes in mucoepidermoid carcinoma. | 4.87e-08 | 3 | 128 | 3 | 21072847 | |
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 7543104 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 4.87e-08 | 3 | 128 | 3 | 17592322 | |
| Pubmed | 4.87e-08 | 3 | 128 | 3 | 35879412 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 4.87e-08 | 3 | 128 | 3 | 1713533 | |
| Pubmed | 4.93e-08 | 54 | 128 | 6 | 35474131 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | KRT1 SMG1 KRT5 MYO9A MUC16 BPTF PTPRH UBAP2L LSM14A DUSP10 SPEN UNC80 | 5.53e-08 | 420 | 128 | 12 | 28065597 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SMCHD1 DIDO1 SRBD1 ECPAS BPTF GTF2F2 KMT2A SPEN SAP130 HCFC1 ZNF687 | 6.01e-08 | 341 | 128 | 11 | 32971831 |
| Pubmed | 6.16e-08 | 267 | 128 | 10 | 33417871 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.61e-08 | 202 | 128 | 9 | 33005030 | |
| Pubmed | KRT1 KRT5 KRT6A KRT6B KRT78 CDKN2AIP FLG2 XRCC5 KRT6C PCBP1 YTHDF2 | 6.96e-08 | 346 | 128 | 11 | 25324306 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | KRT6A RC3H2 KRT78 MYCBP2 INO80 TTC3 LMO7 UBAP2L PHF3 CD44 FAM83D SPEN PCBP1 PALLD YTHDF2 | 7.78e-08 | 724 | 128 | 15 | 36232890 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CDKN2AIP SMCHD1 LIN54 YEATS2 GTF2F2 UBAP2L PHF3 NFRKB PCBP1 PALLD HCFC1 YTHDF2 | 1.01e-07 | 444 | 128 | 12 | 34795231 |
| Pubmed | 1.17e-07 | 286 | 128 | 10 | 32041737 | ||
| Pubmed | 1.24e-07 | 156 | 128 | 8 | 37108203 | ||
| Pubmed | 1.66e-07 | 225 | 128 | 9 | 12168954 | ||
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | IGLV3-32 IGLV3-27 IGLV3-25 IGLV3-16 IGLV2-14 IGLV2-11 IGLV2-8 | 1.69e-07 | 109 | 128 | 7 | 9074928 |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 1.94e-07 | 4 | 128 | 3 | 39024979 | |
| Pubmed | 3.27e-07 | 177 | 128 | 8 | 26206133 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CDKN2AIP TBC1D2B NBEA ECPAS GTF2F2 LMO7 SAP30BP NAV2 KMT2A MUC4 HCFC1 ZNF687 | 3.37e-07 | 497 | 128 | 12 | 36774506 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CDKN2AIP SMCHD1 DIDO1 XRCC5 WNK1 YEATS2 GTF2F2 UBAP2L SAP30BP KMT2A LSM14A PRKDC PCBP1 PALLD HCFC1 YTHDF2 | 3.64e-07 | 934 | 128 | 16 | 33916271 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | KRT1 KRT6B CDKN2AIP SMCHD1 LIN54 DIDO1 HUWE1 XRCC5 YEATS2 UBAP2L SAP30BP NFRKB KMT2A PRKDC PCBP1 SAP130 HCFC1 LRIF1 ZNF687 | 3.77e-07 | 1318 | 128 | 19 | 30463901 |
| Pubmed | KRT1 KRT5 KRT6A KRT6B KRT78 MUC16 FAT2 SLC12A2 CD44 MUC1 MUC4 | 4.48e-07 | 417 | 128 | 11 | 19199708 | |
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 4.84e-07 | 5 | 128 | 3 | 12557214 | |
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 23075894 | ||
| Pubmed | Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. | 4.84e-07 | 5 | 128 | 3 | 38693267 | |
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 20301457 | ||
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 4.84e-07 | 5 | 128 | 3 | 1713141 | |
| Pubmed | 5.37e-07 | 43 | 128 | 5 | 1249422 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYCBP2 MYO9A HIPK2 TNRC6C HUWE1 ECPAS XRCC5 TTC3 WDR37 SLC1A1 YEATS2 BPTF NETO1 UBAP2L NECTIN2 LSM14A PCDH1 SAP130 TMCC1 VPS13B | 5.47e-07 | 1489 | 128 | 20 | 28611215 |
| Pubmed | CDKN2AIP DIDO1 INO80 SRBD1 RABL3 RBM23 FAM83B GTF2F2 SLC12A2 PHF3 SAP30BP NFRKB KMT2A FAM83D LSM14A DGCR8 EXOC2 SPEN TMCC1 ZNF687 | 5.94e-07 | 1497 | 128 | 20 | 31527615 | |
| Pubmed | Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. | 6.50e-07 | 19 | 128 | 4 | 17002498 | |
| Pubmed | 6.75e-07 | 266 | 128 | 9 | 19380743 | ||
| Pubmed | KRT1 KRT6A RC3H2 SMCHD1 DIDO1 FLG2 XRCC5 RBM23 TBC1D10B LMO7 UBAP2L PHF3 TUBGCP3 SAP30BP KMT2A LSM14A PCBP1 HCFC1 YTHDF2 | 6.82e-07 | 1371 | 128 | 19 | 36244648 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KRT78 MYCBP2 MYO9A WNK1 FAM83B TBC1D10B SLC12A2 LMO7 PHF3 NECTIN2 NAV2 KMT2A PALLD TMCC1 YTHDF2 | 7.02e-07 | 861 | 128 | 15 | 36931259 |
| Pubmed | KRT1 KRT5 KRT6B KRT78 FLG2 XRCC5 TBC1D10B KRT6C UBAP2L PRKDC EXOC2 PCBP1 YTHDF2 | 7.66e-07 | 641 | 128 | 13 | 36057605 | |
| Pubmed | 8.16e-07 | 86 | 128 | 6 | 37253089 | ||
| Pubmed | 8.46e-07 | 47 | 128 | 5 | 814163 | ||
| Pubmed | 8.88e-07 | 202 | 128 | 8 | 24639526 | ||
| Pubmed | KRT1 KRT6B SMCHD1 SUN1 DIDO1 XRCC5 SARNP IGLV2-14 LMO7 PRKDC PCBP1 HCFC1 LRIF1 | 9.25e-07 | 652 | 128 | 13 | 31180492 | |
| Pubmed | MYCBP2 SMCHD1 DIDO1 HUWE1 ECPAS XRCC5 BPTF UBAP2L PHF3 KMT2A PRKDC SPEN HCFC1 | 9.41e-07 | 653 | 128 | 13 | 22586326 | |
| Pubmed | 9.41e-07 | 48 | 128 | 5 | 11955599 | ||
| Pubmed | 9.66e-07 | 6 | 128 | 3 | 16239341 | ||
| Pubmed | 9.66e-07 | 6 | 128 | 3 | 16790075 | ||
| Pubmed | p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. | 9.66e-07 | 6 | 128 | 3 | 25383540 | |
| Pubmed | AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. | 9.98e-07 | 21 | 128 | 4 | 18824566 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT1 KRT4 KRT5 KRT6A KRT6B SMCHD1 DIDO1 HUWE1 FLG2 XRCC5 WNK1 GTF2F2 KRT6C UBAP2L PRKDC EXOC2 PCBP1 PALLD HCFC1 | 1.09e-06 | 1415 | 128 | 19 | 28515276 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.68e-06 | 220 | 128 | 8 | 35785414 | |
| Pubmed | 1.69e-06 | 7 | 128 | 3 | 19720911 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.00e-06 | 157 | 128 | 7 | 30686591 | |
| Pubmed | Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8. | 2.69e-06 | 8 | 128 | 3 | 24449888 | |
| Pubmed | 2.94e-06 | 107 | 128 | 6 | 30995489 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | MYCBP2 DIDO1 HUWE1 FLG2 XRCC5 TTC3 YEATS2 LMO7 UBAP2L PCBP1 HCFC1 ZNF687 | 3.59e-06 | 624 | 128 | 12 | 33729478 |
| Pubmed | 3.74e-06 | 245 | 128 | 8 | 35652658 | ||
| Pubmed | 3.87e-06 | 29 | 128 | 4 | 28049658 | ||
| Pubmed | 4.02e-06 | 9 | 128 | 3 | 16093647 | ||
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 4.02e-06 | 9 | 128 | 3 | 16180309 | |
| Pubmed | 4.02e-06 | 9 | 128 | 3 | 15737194 | ||
| Pubmed | RIP4 regulates epidermal differentiation and cutaneous inflammation. | 4.02e-06 | 9 | 128 | 3 | 19626033 | |
| Interaction | KRT25 interactions | 3.14e-11 | 35 | 123 | 8 | int:KRT25 | |
| Interaction | KRT28 interactions | 4.81e-10 | 30 | 123 | 7 | int:KRT28 | |
| Interaction | KRT26 interactions | 1.55e-09 | 35 | 123 | 7 | int:KRT26 | |
| Interaction | HDAC2 interactions | KRT1 KRT5 KRT6A KRT6B KRT78 MYCBP2 CDKN2AIP HUWE1 XRCC5 WNK1 RFX3 TFDP1 BPTF TUBGCP3 CD44 KMT2A LSM14A PRKDC EXOC2 SPEN SAP130 HCFC1 ZNF687 | 2.28e-09 | 865 | 123 | 23 | int:HDAC2 |
| Interaction | KRT36 interactions | 1.65e-08 | 74 | 123 | 8 | int:KRT36 | |
| Interaction | POU5F1 interactions | KRT1 SMCHD1 MUC16 INO80 HUWE1 ECPAS XRCC5 YEATS2 BPTF UBAP2L PHF3 TUBGCP3 SAP30BP NFRKB PRKDC SAP130 HCFC1 BRWD1 | 1.66e-08 | 584 | 123 | 18 | int:POU5F1 |
| Interaction | RNF208 interactions | 1.83e-08 | 75 | 123 | 8 | int:RNF208 | |
| Interaction | H3-3A interactions | SMCHD1 LIN54 DIDO1 INO80 ITGA4 SRBD1 XRCC5 TFDP1 BPTF GTF2F2 PHF3 NFRKB KMT2A PRKDC USF1 SPEN SAP130 HCFC1 LRIF1 BRWD1 | 2.70e-08 | 749 | 123 | 20 | int:H3-3A |
| Interaction | KRT13 interactions | 3.85e-08 | 116 | 123 | 9 | int:KRT13 | |
| Interaction | TERF2IP interactions | SMCHD1 LIN54 DIDO1 XRCC5 SARNP YEATS2 BPTF PHF3 SAP30BP NFRKB KMT2A DGCR8 SPEN SAP130 HCFC1 LRIF1 ZNF687 | 4.37e-08 | 552 | 123 | 17 | int:TERF2IP |
| Interaction | PHTF1 interactions | 1.12e-07 | 20 | 123 | 5 | int:PHTF1 | |
| Interaction | YAP1 interactions | KRT1 KRT6A KRT6B SMCHD1 DIDO1 HUWE1 FLG2 XRCC5 BPTF GTF2F2 KRT76 UBAP2L PHF3 SAP30BP NFRKB KMT2A DGCR8 PRKDC SPEN PCBP1 SAP130 PALLD HCFC1 | 1.76e-07 | 1095 | 123 | 23 | int:YAP1 |
| Interaction | HNRNPA1 interactions | KRT1 KRT5 KRT6A RC3H2 KRT6B KRT78 CDKN2AIP ITGA4 FLG2 ECPAS XRCC5 FREM2 KRT6C PHF3 SUPV3L1 TUBGCP3 ALPK3 LSM14A PRKDC PCBP1 YTHDF2 | 2.60e-07 | 945 | 123 | 21 | int:HNRNPA1 |
| Interaction | KRT16 interactions | 3.65e-07 | 197 | 123 | 10 | int:KRT16 | |
| Interaction | ASF1A interactions | LIN54 YEATS2 GTF2F2 PHF3 NFRKB KMT2A SPEN SAP130 HCFC1 LRIF1 ZNF687 | 3.75e-07 | 249 | 123 | 11 | int:ASF1A |
| Interaction | DDX39B interactions | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 HIPK2 HUWE1 ITGA4 FLG2 XRCC5 SARNP KRT6C LMO7 PRKDC PCBP1 | 3.93e-07 | 570 | 123 | 16 | int:DDX39B |
| Interaction | KRT35 interactions | 4.00e-07 | 111 | 123 | 8 | int:KRT35 | |
| Interaction | KRT7 interactions | 5.83e-07 | 80 | 123 | 7 | int:KRT7 | |
| Interaction | SMC5 interactions | CDKN2AIP SMCHD1 LIN54 DIDO1 XRCC5 SARNP YEATS2 BPTF GTF2F2 UBAP2L PHF3 SAP30BP NFRKB KMT2A DGCR8 PRKDC SPEN PCBP1 SAP130 HCFC1 YTHDF2 | 6.56e-07 | 1000 | 123 | 21 | int:SMC5 |
| Interaction | YY1 interactions | SMCHD1 LIN54 DIDO1 INO80 XRCC5 TFDP1 YEATS2 BPTF NFRKB KMT2A PRKDC HCFC1 LRIF1 ZNF687 | 7.32e-07 | 454 | 123 | 14 | int:YY1 |
| Interaction | XRCC6 interactions | RC3H2 CDKN2AIP SMCHD1 LIN54 DIDO1 HUWE1 ITGA4 XRCC5 SARNP BPTF GTF2F2 PHF3 SAP30BP KMT2A DGCR8 PRKDC USF1 SPEN PCBP1 HCFC1 | 8.41e-07 | 928 | 123 | 20 | int:XRCC6 |
| Interaction | KRT24 interactions | 9.29e-07 | 54 | 123 | 6 | int:KRT24 | |
| Interaction | ELF1 interactions | 1.05e-06 | 126 | 123 | 8 | int:ELF1 | |
| Interaction | KRT38 interactions | 1.11e-06 | 172 | 123 | 9 | int:KRT38 | |
| Interaction | ZUP1 interactions | 1.23e-06 | 174 | 123 | 9 | int:ZUP1 | |
| Interaction | KRT15 interactions | 1.48e-06 | 178 | 123 | 9 | int:KRT15 | |
| Interaction | KRT33B interactions | 1.63e-06 | 93 | 123 | 7 | int:KRT33B | |
| Interaction | H2BC8 interactions | SMCHD1 LIN54 DIDO1 ITGA4 SRBD1 XRCC5 SARNP BPTF GTF2F2 PHF3 NFRKB KMT2A SPEN LRIF1 ZNF687 | 2.36e-06 | 576 | 123 | 15 | int:H2BC8 |
| Interaction | MYCN interactions | KRT1 KRT5 KRT6A KRT78 CDKN2AIP SMCHD1 DIDO1 TNRC6C HUWE1 SRBD1 FLG2 XRCC5 SARNP TBC1D10B UBAP2L PHF3 SUPV3L1 SAP30BP KMT2A LSM14A DGCR8 PRKDC PCBP1 HCFC1 | 2.47e-06 | 1373 | 123 | 24 | int:MYCN |
| Interaction | KRT37 interactions | 2.66e-06 | 100 | 123 | 7 | int:KRT37 | |
| Interaction | KRT14 interactions | 2.77e-06 | 192 | 123 | 9 | int:KRT14 | |
| Interaction | KRT17 interactions | 3.40e-06 | 252 | 123 | 10 | int:KRT17 | |
| Interaction | CIC interactions | SMCHD1 LIN54 HUWE1 SRBD1 FLG2 XRCC5 TFDP1 PHF3 LSM14A PRKDC USF1 PCBP1 SAP130 HCFC1 YTHDF2 ZNF687 | 3.43e-06 | 673 | 123 | 16 | int:CIC |
| Interaction | CHD3 interactions | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 FLG2 XRCC5 SARNP BPTF KRT6C KMT2A PRKDC PCBP1 SAP130 LRIF1 ZNF687 | 3.55e-06 | 757 | 123 | 17 | int:CHD3 |
| Interaction | UHRF2 interactions | 3.87e-06 | 200 | 123 | 9 | int:UHRF2 | |
| Interaction | LRRC31 interactions | 4.73e-06 | 205 | 123 | 9 | int:LRRC31 | |
| Interaction | H2BC21 interactions | SMCHD1 HIPK2 DIDO1 HUWE1 SRBD1 XRCC5 YEATS2 BPTF ADHFE1 OTOF PHF3 KMT2A PRKDC HCFC1 LRIF1 ZNF687 | 5.25e-06 | 696 | 123 | 16 | int:H2BC21 |
| Interaction | CYLD interactions | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 MUC19 TNRC6C HUWE1 FLG2 ECPAS XRCC5 YEATS2 CD44 PRKDC PCBP1 PALLD YTHDF2 | 5.41e-06 | 868 | 123 | 18 | int:CYLD |
| Interaction | KLF8 interactions | LIN54 INO80 TFDP1 YEATS2 BPTF NFRKB LSM14A DGCR8 SPEN SAP130 YTHDF2 | 5.63e-06 | 329 | 123 | 11 | int:KLF8 |
| Interaction | FHL2 interactions | HIPK2 WNK1 RFX3 YEATS2 GTF2F2 SAP30BP DUSP10 USF1 SPEN SAP130 LRIF1 MRTFA | 5.67e-06 | 396 | 123 | 12 | int:FHL2 |
| Interaction | CEBPA interactions | MYCBP2 CDKN2AIP SMCHD1 LIN54 DIDO1 ECPAS XRCC5 SARNP YEATS2 BPTF GTF2F2 TUBGCP3 NFRKB KMT2A LSM14A PRKDC USF1 SPEN SAP130 HCFC1 LRIF1 ZNF687 | 5.86e-06 | 1245 | 123 | 22 | int:CEBPA |
| Interaction | ELF4 interactions | 6.75e-06 | 115 | 123 | 7 | int:ELF4 | |
| Interaction | ZC3H7A interactions | 6.96e-06 | 215 | 123 | 9 | int:ZC3H7A | |
| Interaction | PPIA interactions | KRT6B DIDO1 HUWE1 ITGA4 SRBD1 ECPAS SARNP YEATS2 BPTF GTF2F2 PHF3 NECTIN2 CD44 SAP130 HCFC1 YTHDF2 MRTFA ZNF687 | 7.39e-06 | 888 | 123 | 18 | int:PPIA |
| Interaction | NANOG interactions | KRT1 KRT5 KRT6B MUC16 DIDO1 HUWE1 ECPAS XRCC5 YEATS2 BPTF TUBGCP3 SAP130 HCFC1 | 7.83e-06 | 481 | 123 | 13 | int:NANOG |
| Interaction | HECTD1 interactions | MYCBP2 MYO9B SMCHD1 DIDO1 HUWE1 SRBD1 XRCC5 SARNP BPTF UBAP2L PHF3 MCM9 TUBGCP3 LSM14A DGCR8 PRKDC EXOC2 SAP130 YTHDF2 | 8.02e-06 | 984 | 123 | 19 | int:HECTD1 |
| Interaction | FBP1 interactions | KRT1 KRT5 KRT6A SMCHD1 DIDO1 FLG2 XRCC5 LMO7 UBAP2L LSM14A PRKDC | 9.56e-06 | 348 | 123 | 11 | int:FBP1 |
| Interaction | DDX3X interactions | KRT1 SMG1 KRT4 KRT5 KRT6A RC3H2 KRT6B KRT78 MYCBP2 ITGA4 FLG2 TBC1D10B LSM14A PCBP1 YTHDF2 | 1.03e-05 | 651 | 123 | 15 | int:DDX3X |
| Interaction | H3C3 interactions | SMCHD1 LIN54 DIDO1 ITGA4 SRBD1 XRCC5 BPTF GTF2F2 PHF3 NFRKB KMT2A SPEN LRIF1 | 1.06e-05 | 495 | 123 | 13 | int:H3C3 |
| Interaction | BMI1 interactions | DIDO1 XRCC5 KRT76 LMO7 UBAP2L PHF3 KMT2A LSM14A DGCR8 PRKDC SPEN MUC1 LRIF1 YTHDF2 ZNF687 | 1.19e-05 | 659 | 123 | 15 | int:BMI1 |
| Interaction | KRT84 interactions | 1.20e-05 | 49 | 123 | 5 | int:KRT84 | |
| Interaction | KRT12 interactions | 1.28e-05 | 24 | 123 | 4 | int:KRT12 | |
| Interaction | USF1 interactions | 1.35e-05 | 85 | 123 | 6 | int:USF1 | |
| Interaction | KRT8 interactions | KRT1 SMG1 KRT5 KRT6A KRT6B TBC1D2B TNRC6C ITGA4 TTC3 FAM83B KRT76 KRT6C | 1.67e-05 | 441 | 123 | 12 | int:KRT8 |
| Interaction | CRK interactions | KRT1 KRT4 KRT5 KRT6A KRT6B KRT78 HUWE1 KRT76 PTPRH SPEN ADGRL3 | 1.69e-05 | 370 | 123 | 11 | int:CRK |
| Interaction | CIT interactions | DSCAM MYO9B SMCHD1 SUN1 DIDO1 ITGA4 SRBD1 ECPAS XRCC5 TTC3 SARNP RBM23 BPTF TBC1D10B EFEMP1 LMO7 UBAP2L CD44 KMT2A PRKDC PCBP1 HCFC1 ZNF687 | 2.02e-05 | 1450 | 123 | 23 | int:CIT |
| Interaction | KCNA3 interactions | MYO9A ECPAS XRCC5 SLC1A1 FAM83B YEATS2 TBC1D10B UBAP2L PHF3 NECTIN2 KMT2A PRKDC SPEN PCBP1 PALLD HCFC1 YTHDF2 | 2.21e-05 | 871 | 123 | 17 | int:KCNA3 |
| Interaction | KBTBD4 interactions | 2.45e-05 | 316 | 123 | 10 | int:KBTBD4 | |
| Interaction | PRPS2 interactions | 2.55e-05 | 253 | 123 | 9 | int:PRPS2 | |
| Interaction | NUP43 interactions | DSCAM CDKN2AIP LIN54 MUC19 INO80 TFDP1 YEATS2 BPTF NETO1 NFRKB KMT2A SPEN HCFC1 ZNF687 | 2.83e-05 | 625 | 123 | 14 | int:NUP43 |
| Interaction | AR interactions | MYCBP2 SMCHD1 LIN54 HIPK2 DIDO1 HUWE1 ECPAS XRCC5 GTF2F2 UBAP2L PHF3 NFRKB KMT2A FAM83D PRKDC PCBP1 SAP130 HCFC1 | 3.26e-05 | 992 | 123 | 18 | int:AR |
| Interaction | KRT27 interactions | 3.41e-05 | 202 | 123 | 8 | int:KRT27 | |
| Interaction | EWSR1 interactions | RC3H2 KRT6B MYCBP2 ITGA4 XRCC5 WDR37 SARNP RFX3 SLC1A1 GTF2F2 UBAP2L SAP30BP NFRKB KMT2A DGCR8 USF1 PCBP1 | 3.63e-05 | 906 | 123 | 17 | int:EWSR1 |
| Interaction | COPS5 interactions | KRT1 KRT5 KRT6A KRT6B KRT78 DSCAM HUWE1 FLG2 TTC3 WNK1 KRT76 KRT6C UBAP2L PRKDC PCBP1 SAP130 YTHDF2 UNC80 BRWD1 | 3.86e-05 | 1102 | 123 | 19 | int:COPS5 |
| Interaction | KRT20 interactions | 4.13e-05 | 63 | 123 | 5 | int:KRT20 | |
| Interaction | RNF214 interactions | 4.26e-05 | 104 | 123 | 6 | int:RNF214 | |
| Interaction | BRD3 interactions | MYO9B SMCHD1 INO80 SARNP TFDP1 BPTF TBC1D10B GTF2F2 SAP30BP NFRKB KMT2A ZNF687 | 5.05e-05 | 494 | 123 | 12 | int:BRD3 |
| Interaction | PML interactions | SMCHD1 LIN54 HIPK2 YEATS2 GTF2F2 LMO7 UBAP2L PHF3 NFRKB KMT2A USF1 PCBP1 SAP130 PALLD HCFC1 YTHDF2 ZNF687 | 5.23e-05 | 933 | 123 | 17 | int:PML |
| Interaction | KRT18 interactions | KRT1 KRT4 KRT5 KRT6A KRT6B SMCHD1 HUWE1 ITGA4 FAM83B KRT76 KRT6C | 5.27e-05 | 419 | 123 | 11 | int:KRT18 |
| Interaction | DES interactions | 5.29e-05 | 158 | 123 | 7 | int:DES | |
| Interaction | DCTN1 interactions | KRT5 KRT6A KRT6B MYCBP2 HUWE1 ECPAS KRT76 KRT6C SAP30BP FAM83D PCBP1 YTHDF2 | 5.35e-05 | 497 | 123 | 12 | int:DCTN1 |
| Interaction | KRT19 interactions | 5.93e-05 | 282 | 123 | 9 | int:KRT19 | |
| Interaction | SUMO2 interactions | KRT5 SMCHD1 HIPK2 DIDO1 HUWE1 XRCC5 BPTF LMO7 UBAP2L PHF3 PRKDC PALLD HCFC1 | 6.69e-05 | 591 | 123 | 13 | int:SUMO2 |
| Interaction | ANKRD17 interactions | 7.53e-05 | 226 | 123 | 8 | int:ANKRD17 | |
| Interaction | APEX1 interactions | MYO9A SMCHD1 LIN54 DIDO1 INO80 XRCC5 TTC3 BPTF TBC1D10B GTF2F2 PHF3 NECTIN2 CD44 KMT2A LSM14A PRKDC TMCC1 MRTFA SEZ6 BRWD1 | 8.45e-05 | 1271 | 123 | 20 | int:APEX1 |
| Interaction | UBAP2L interactions | 9.04e-05 | 298 | 123 | 9 | int:UBAP2L | |
| Interaction | ARL14 interactions | 9.04e-05 | 119 | 123 | 6 | int:ARL14 | |
| Interaction | IQCB1 interactions | 9.19e-05 | 370 | 123 | 10 | int:IQCB1 | |
| Interaction | CENPA interactions | SMCHD1 SRBD1 ECPAS XRCC5 BPTF GTF2F2 KMT2A PRKDC HCFC1 BRWD1 | 1.07e-04 | 377 | 123 | 10 | int:CENPA |
| Interaction | EFNA4 interactions | 1.11e-04 | 239 | 123 | 8 | int:EFNA4 | |
| Interaction | FBXO22 interactions | CDKN2AIP TBC1D2B NBEA ECPAS GTF2F2 LMO7 SAP30BP NAV2 KMT2A MUC4 HCFC1 ZNF687 | 1.17e-04 | 540 | 123 | 12 | int:FBXO22 |
| Interaction | DYNLT1 interactions | 1.18e-04 | 241 | 123 | 8 | int:DYNLT1 | |
| Interaction | H3C1 interactions | SMCHD1 DIDO1 ITGA4 SRBD1 XRCC5 SARNP BPTF GTF2F2 PHF3 NAV2 KMT2A PRKDC USF1 SPEN PALLD LRIF1 | 1.19e-04 | 901 | 123 | 16 | int:H3C1 |
| Interaction | WDR5 interactions | KRT1 KRT6B CHMP1B CDKN2AIP SMCHD1 INO80 ECPAS XRCC5 TFDP1 YEATS2 LMO7 UBAP2L KMT2A PRKDC USF1 PCBP1 HCFC1 LRIF1 | 1.24e-04 | 1101 | 123 | 18 | int:WDR5 |
| Interaction | BRCA2 interactions | 1.25e-04 | 384 | 123 | 10 | int:BRCA2 | |
| Interaction | TRIM37 interactions | KRT1 KRT5 KRT6A KRT6B DSCAM TBC1D2B HUWE1 XRCC5 YEATS2 NFRKB PRKDC SPEN PALLD | 1.27e-04 | 630 | 123 | 13 | int:TRIM37 |
| Interaction | THRB interactions | 1.47e-04 | 186 | 123 | 7 | int:THRB | |
| Interaction | KRT32 interactions | 1.49e-04 | 44 | 123 | 4 | int:KRT32 | |
| Interaction | KRT10 interactions | 1.52e-04 | 187 | 123 | 7 | int:KRT10 | |
| Interaction | LINC00839 interactions | 1.55e-04 | 83 | 123 | 5 | int:LINC00839 | |
| Interaction | KIFC3 interactions | 1.60e-04 | 252 | 123 | 8 | int:KIFC3 | |
| Interaction | FAM120C interactions | 1.73e-04 | 191 | 123 | 7 | int:FAM120C | |
| Interaction | LSM14A interactions | 1.98e-04 | 260 | 123 | 8 | int:LSM14A | |
| Interaction | LGR4 interactions | 2.08e-04 | 262 | 123 | 8 | int:LGR4 | |
| Interaction | CNOT10 interactions | 2.29e-04 | 141 | 123 | 6 | int:CNOT10 | |
| Interaction | PCBP1 interactions | RC3H2 MYO9B HUWE1 ITGA4 XRCC5 SARNP TFDP1 UBAP2L PHF3 TUBGCP3 LSM14A PRKDC PCBP1 | 2.35e-04 | 671 | 123 | 13 | int:PCBP1 |
| Interaction | HMGA1 interactions | 2.52e-04 | 419 | 123 | 10 | int:HMGA1 | |
| Interaction | PRPH interactions | 2.59e-04 | 204 | 123 | 7 | int:PRPH | |
| Interaction | RBM47 interactions | 2.59e-04 | 204 | 123 | 7 | int:RBM47 | |
| Interaction | RNF8 interactions | 2.62e-04 | 421 | 123 | 10 | int:RNF8 | |
| Cytoband | 12q13.13 | 1.66e-11 | 67 | 128 | 8 | 12q13.13 | |
| Cytoband | 22q11.2 | IGLV3-32 IGLV3-27 IGLV3-25 IGLV3-16 IGLV2-14 IGLV2-11 IGLV2-8 DGCR8 | 1.89e-09 | 120 | 128 | 8 | 22q11.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 3.19e-06 | 423 | 128 | 9 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | IGLV3-32 IGLV3-27 IGLV3-25 IGLV3-16 IGLV2-14 IGLV2-11 IGLV2-8 DGCR8 | 2.48e-05 | 419 | 128 | 8 | chr22q11 |
| Cytoband | 21q22.2 | 1.09e-04 | 33 | 128 | 3 | 21q22.2 | |
| GeneFamily | Keratins, type II | 4.68e-13 | 27 | 88 | 8 | 609 | |
| GeneFamily | CD molecules|Mucins | 5.58e-12 | 21 | 88 | 7 | 648 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | IGLV3-32 IGLV3-27 IGLV3-25 IGLV3-16 IGLV2-14 IGLV2-11 IGLV2-8 | 2.53e-07 | 89 | 88 | 7 | 353 |
| GeneFamily | Myosins, class IX | 2.34e-05 | 2 | 88 | 2 | 1103 | |
| GeneFamily | PHD finger proteins | 9.73e-04 | 90 | 88 | 4 | 88 | |
| GeneFamily | Non-clustered protocadherins | 1.50e-03 | 12 | 88 | 2 | 21 | |
| GeneFamily | ATAC complex | 1.76e-03 | 13 | 88 | 2 | 1058 | |
| GeneFamily | INO80 complex |SRCAP complex | 2.36e-03 | 15 | 88 | 2 | 595 | |
| GeneFamily | Apolipoproteins | 4.63e-03 | 21 | 88 | 2 | 405 | |
| Coexpression | NABA_ECM_AFFILIATED | 9.43e-09 | 170 | 125 | 10 | M5880 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 4.00e-08 | 69 | 125 | 7 | M2533 | |
| Coexpression | NABA_ECM_AFFILIATED | 7.04e-08 | 158 | 125 | 9 | MM17063 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 8.20e-07 | 67 | 125 | 6 | M40299 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.85e-06 | 300 | 125 | 10 | M8702 | |
| Coexpression | YUAN_ZNF143_PARTNERS | 3.37e-06 | 22 | 125 | 4 | M2355 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN | 2.88e-05 | 37 | 125 | 4 | M16944 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 2.92e-05 | 13 | 125 | 3 | MM743 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 4.90e-05 | 199 | 125 | 7 | M7319 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 4.90e-05 | 199 | 125 | 7 | M9236 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS | 5.81e-05 | 140 | 125 | 6 | M40004 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 MYCBP2 MYO9B SMCHD1 TBC1D2B TNRC6C HUWE1 ITGA4 XRCC5 WNK1 BPTF PHF3 CD44 KMT2A LSM14A SPEN PCBP1 VPS13B BRWD1 | 8.40e-05 | 1492 | 125 | 19 | M40023 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | PLXNA3 DSCAM HIPK2 NBEA APOL1 SLC1A1 EFEMP1 SLC12A2 ATRNL1 NECTIN2 CD44 DUSP10 SDK1 | 1.00e-04 | 786 | 125 | 13 | M10961 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | 1.26e-05 | 132 | 124 | 7 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 MYCBP2 HIPK2 INO80 HUWE1 ECPAS BPTF PHF3 MUC1 VPS13B BRWD1 | 1.41e-05 | 379 | 124 | 11 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 2.38e-05 | 98 | 124 | 6 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | CHMP1B HIPK2 NBEA HUWE1 ITGA4 WDR37 SLC1A1 EFEMP1 LMO7 MCM9 EXOC2 PCDH8 UNC80 ADGRL3 BRWD1 | 9.73e-05 | 827 | 124 | 15 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | esophagus | 1.03e-04 | 247 | 124 | 8 | esophagus | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | MYCBP2 TRO SMCHD1 DIDO1 INO80 ECPAS WNK1 BPTF UBAP2L LSM14A EXOC2 BRWD1 | 1.17e-04 | 564 | 124 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | BM Top 100 - esophagus | 1.49e-04 | 86 | 124 | 5 | BM Top 100 - esophagus | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | PLXNA3 RC3H2 HIPK2 TTC3 WDR37 SARNP GTF2F2 UBAP2L DGCR8 HCFC1 EMCN | 1.65e-04 | 498 | 124 | 11 | gudmap_developingGonad_e11.5_testes_k5_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | HUWE1 ITGA4 MAGEE1 WDR37 THBS2 NETO1 MCM9 PCDH8 ADGRL3 BRWD1 | 1.88e-04 | 422 | 124 | 10 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | PLXNA3 RC3H2 SUN1 ECPAS WDR37 SARNP GTF2F2 UBAP2L NECTIN2 HCFC1 | 2.15e-04 | 429 | 124 | 10 | gudmap_developingGonad_e14.5_ testes_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.44e-04 | 149 | 124 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | SMG1 KRT4 KRT5 KRT6A MYCBP2 HIPK2 INO80 TNRC6C HUWE1 ITGA4 EFEMP1 PHF3 EXOC2 ADGRL3 | 2.63e-04 | 806 | 124 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.30e-09 | 184 | 128 | 9 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.99e-09 | 197 | 128 | 9 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.26e-09 | 198 | 128 | 9 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.58e-08 | 171 | 128 | 8 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.58e-08 | 171 | 128 | 8 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 3.75e-08 | 172 | 128 | 8 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.48e-08 | 176 | 128 | 8 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 4.89e-08 | 178 | 128 | 8 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 6.59e-08 | 185 | 128 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.87e-08 | 186 | 128 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Club-club-5|World / Class top | 7.46e-08 | 188 | 128 | 8 | 5911409108ececdb4f8112ec4bacc215e204001f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.77e-08 | 189 | 128 | 8 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.43e-08 | 191 | 128 | 8 | cd4e2e883c4955fb2d875e41bb6ebc680994dc8c | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.43e-08 | 191 | 128 | 8 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.43e-08 | 191 | 128 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.50e-08 | 194 | 128 | 8 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.89e-08 | 195 | 128 | 8 | dd8117dbd22892288f74a7314ab0b5080106936c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.89e-08 | 195 | 128 | 8 | 82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-08 | 195 | 128 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-08 | 195 | 128 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-07 | 196 | 128 | 8 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-07 | 197 | 128 | 8 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.07e-07 | 197 | 128 | 8 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-07 | 197 | 128 | 8 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-07 | 197 | 128 | 8 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.07e-07 | 197 | 128 | 8 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-07 | 198 | 128 | 8 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-07 | 198 | 128 | 8 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-07 | 198 | 128 | 8 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-07 | 198 | 128 | 8 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-07 | 199 | 128 | 8 | 5a1557fe35aa48080d4967e8724bf27f9585a5fb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-07 | 199 | 128 | 8 | 0a657475b92aa3a713da62da364525249fdc3886 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-07 | 199 | 128 | 8 | a8f4bd0e65f36b29535864fae4347369d5c864d2 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-07 | 199 | 128 | 8 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-07 | 199 | 128 | 8 | eacea42e973f073b410f54c0a1b3a7f2dc2b5a29 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.20e-07 | 200 | 128 | 8 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.20e-07 | 200 | 128 | 8 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-07 | 200 | 128 | 8 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-07 | 200 | 128 | 8 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.20e-07 | 200 | 128 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-07 | 159 | 128 | 7 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.71e-07 | 163 | 128 | 7 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.50e-07 | 171 | 128 | 7 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-07 | 173 | 128 | 7 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.03e-07 | 173 | 128 | 7 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.31e-07 | 174 | 128 | 7 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.60e-07 | 175 | 128 | 7 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.60e-07 | 175 | 128 | 7 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-07 | 175 | 128 | 7 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.20e-07 | 177 | 128 | 7 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.52e-07 | 181 | 128 | 7 | faff2a34e391d053a17c926540e6cb46d94dd629 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.52e-07 | 181 | 128 | 7 | 5a9c332c0bf07cc20eaf8cf77b45e73668a6467d | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.52e-07 | 181 | 128 | 7 | 488a517f6e5543b648a2e72e0e04332fad776de6 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.52e-07 | 181 | 128 | 7 | 58651853f9c715075889856793df66ebe00c04f1 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 9.52e-07 | 181 | 128 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.03e-06 | 183 | 128 | 7 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-06 | 185 | 128 | 7 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 185 | 128 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | facs-Trachea-nan-18m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 187 | 128 | 7 | 8882a638af7165b2910ba8e932d55475d7bfb003 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.18e-06 | 187 | 128 | 7 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.23e-06 | 188 | 128 | 7 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.27e-06 | 189 | 128 | 7 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | Control-Epithelial-Basal/Club|Control / Disease group,lineage and cell class （2021.01.30） | 1.32e-06 | 190 | 128 | 7 | 799b0b1c4bdbe04ee0fc34d0be9e02b5992774a0 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.32e-06 | 190 | 128 | 7 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.32e-06 | 190 | 128 | 7 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.32e-06 | 190 | 128 | 7 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-06 | 191 | 128 | 7 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | facs-Trachea-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-06 | 192 | 128 | 7 | c5823c5d4c58a4e9121a4b7d7256481d6d9e9b7f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-06 | 192 | 128 | 7 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.57e-06 | 195 | 128 | 7 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 196 | 128 | 7 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | NS-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.62e-06 | 196 | 128 | 7 | 453c809494ceffa2a28af283c4b5a4924fcf160f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-06 | 196 | 128 | 7 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-06 | 196 | 128 | 7 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 196 | 128 | 7 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 196 | 128 | 7 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-06 | 197 | 128 | 7 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.68e-06 | 197 | 128 | 7 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.68e-06 | 197 | 128 | 7 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-06 | 197 | 128 | 7 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-06 | 197 | 128 | 7 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-06 | 197 | 128 | 7 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-06 | 198 | 128 | 7 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-06 | 198 | 128 | 7 | a54ae5275a510b49d7629f0908817a0c5f05020e | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-06 | 198 | 128 | 7 | 34997e3896d0893fbe51bfb0d4660ccaca1c975e | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-06 | 198 | 128 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-06 | 198 | 128 | 7 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.73e-06 | 198 | 128 | 7 | 686eda427b075e788de38149eae82faf19bd5704 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-06 | 198 | 128 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-06 | 198 | 128 | 7 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-06 | 198 | 128 | 7 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.79e-06 | 199 | 128 | 7 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-06 | 199 | 128 | 7 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-06 | 199 | 128 | 7 | 667e1a56c33a2681af8dc1b7dbc3a9858e2c3c05 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.79e-06 | 199 | 128 | 7 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-06 | 199 | 128 | 7 | 245b37df56dfbbdbac88f0e2fc3dfa0ed1abd588 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-06 | 199 | 128 | 7 | 2dae9db4d25f1a390134da2b6621564b274fe910 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-06 | 199 | 128 | 7 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-06 | 199 | 128 | 7 | dbb33f0e151b150ba9ca4612973f8034c62e762b | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.79e-06 | 199 | 128 | 7 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| Computational | Genes in the cancer module 68. | 1.03e-06 | 26 | 78 | 5 | MODULE_68 | |
| Computational | Keratin. | 1.03e-06 | 26 | 78 | 5 | MODULE_298 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.31e-06 | 49 | 78 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.90e-05 | 50 | 78 | 5 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Genes in the cancer module 153. | 1.01e-04 | 34 | 78 | 4 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.24e-04 | 49 | 78 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.59e-04 | 50 | 78 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes in the cancer module 322. | 8.63e-04 | 59 | 78 | 4 | MODULE_322 | |
| Computational | Genes in the cancer module 318. | 1.06e-03 | 28 | 78 | 3 | MODULE_318 | |
| Drug | SC-791 | 1.21e-08 | 6 | 123 | 4 | CID010291510 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 5.46e-07 | 178 | 123 | 9 | 3998_DN | |
| Drug | homocysteine thiolactone | 5.73e-07 | 131 | 123 | 8 | CID000107712 | |
| Drug | 1,2,3-trioleoylglycerol | 2.41e-06 | 111 | 123 | 7 | CID000031207 | |
| Drug | phenyl isocyanate | 3.04e-06 | 6 | 123 | 3 | ctd:C025319 | |
| Drug | ClOClO | 3.04e-06 | 6 | 123 | 3 | CID000517862 | |
| Drug | HOCl | 3.90e-06 | 169 | 123 | 8 | CID000024341 | |
| Drug | teleocidin B | 4.78e-06 | 123 | 123 | 7 | CID000072425 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.83e-06 | 174 | 123 | 8 | 6493_DN | |
| Drug | sulfur mustard | 6.90e-06 | 130 | 123 | 7 | CID000010461 | |
| Drug | MK-6 | 7.93e-06 | 24 | 123 | 4 | CID005283547 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.58e-06 | 191 | 123 | 8 | 4269_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.07e-05 | 194 | 123 | 8 | 4727_DN | |
| Drug | AC1L2FDK | 1.26e-05 | 9 | 123 | 3 | CID000020024 | |
| Drug | butyrate | KRT1 KRT4 KRT5 KRT6A KRT6B MUC12 CES2 ADHFE1 KRT76 KRT6C CD44 MUC1 MUC4 TMCC1 EMCN | 1.71e-05 | 767 | 123 | 15 | CID000000264 |
| Drug | 2-Formyl-Protoporphryn Ix | 2.28e-05 | 31 | 123 | 4 | CID011963946 | |
| Drug | Contact Lens Solutions | 2.89e-05 | 2 | 123 | 2 | ctd:D018639 | |
| Drug | N-hydroxymethylbenzamide | 2.89e-05 | 2 | 123 | 2 | CID000080493 | |
| Drug | benzyl nicotinate | 2.89e-05 | 2 | 123 | 2 | CID000007191 | |
| Drug | isobutoxy | 2.89e-05 | 2 | 123 | 2 | CID000010557 | |
| Drug | al-Badry | 3.24e-05 | 165 | 123 | 7 | CID000004545 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.24e-05 | 165 | 123 | 7 | 2835_DN | |
| Drug | 2-heptanone | 3.27e-05 | 12 | 123 | 3 | CID000008051 | |
| Drug | tsuwabukinonol | 4.67e-05 | 37 | 123 | 4 | CID006440419 | |
| Drug | cellobiitol | 4.67e-05 | 37 | 123 | 4 | CID000003871 | |
| Drug | chrysarobin | 4.67e-05 | 37 | 123 | 4 | CID000068111 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 4.89e-05 | 176 | 123 | 7 | 6546_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.26e-05 | 178 | 123 | 7 | 7245_DN | |
| Drug | CaLam | 5.76e-05 | 39 | 123 | 4 | CID004126474 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 6.48e-05 | 184 | 123 | 7 | 1835_DN | |
| Drug | 3-deoxy-3-fluoro-D-glucose | 6.68e-05 | 15 | 123 | 3 | CID000450201 | |
| Drug | altanserin | 6.68e-05 | 15 | 123 | 3 | CID003033676 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 7.42e-05 | 188 | 123 | 7 | 6735_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 7.42e-05 | 188 | 123 | 7 | 4845_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 7.93e-05 | 190 | 123 | 7 | 4322_DN | |
| Drug | bilirubin-phosphate | 8.18e-05 | 16 | 123 | 3 | CID005497144 | |
| Drug | tryptophan ethyl ester | 8.65e-05 | 3 | 123 | 2 | CID000081996 | |
| Drug | Boric Acids | 8.65e-05 | 3 | 123 | 2 | ctd:D001888 | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 9.03e-05 | 194 | 123 | 7 | 2735_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 9.03e-05 | 194 | 123 | 7 | 4662_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 9.33e-05 | 195 | 123 | 7 | 5665_UP | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 9.33e-05 | 195 | 123 | 7 | 1132_DN | |
| Drug | yohimbine; Down 200; 22.9uM; MCF7; HT_HG-U133A_EA | 9.33e-05 | 195 | 123 | 7 | 1119_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 3192_DN | |
| Drug | clobestasol propionate | 9.90e-05 | 17 | 123 | 3 | CID000002791 | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.94e-05 | 197 | 123 | 7 | 3335_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; PC3; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 7278_UP | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 4704_DN | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 5827_UP | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 1291_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; HL60; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 1330_UP | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 4567_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; HL60; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 3117_DN | |
| Drug | Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 2806_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A | 1.09e-04 | 200 | 123 | 7 | 1592_DN | |
| Drug | dithranol | 1.18e-04 | 18 | 123 | 3 | CID000002202 | |
| Drug | phenazine ethosulfate | 1.40e-04 | 19 | 123 | 3 | CID000082688 | |
| Drug | mant-GTP | 1.54e-04 | 50 | 123 | 4 | CID000128647 | |
| Drug | Olux | 1.64e-04 | 20 | 123 | 3 | CID000032797 | |
| Drug | AC1NPJ0T | 1.64e-04 | 20 | 123 | 3 | CID005159168 | |
| Drug | N1-acetylspermidine | 1.64e-04 | 20 | 123 | 3 | CID000000496 | |
| Drug | IC86621 | 1.72e-04 | 4 | 123 | 2 | CID009859309 | |
| Drug | bromoacetamide | 1.72e-04 | 4 | 123 | 2 | CID000069632 | |
| Drug | 16 beta-hydroxydigitoxigenin | 1.72e-04 | 4 | 123 | 2 | CID000011012 | |
| Disease | sphingomyelin measurement | 2.48e-06 | 278 | 122 | 9 | EFO_0010118 | |
| Disease | Pachyonychia congenita syndrome | 1.01e-04 | 4 | 122 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.01e-04 | 4 | 122 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.01e-04 | 4 | 122 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.01e-04 | 4 | 122 | 2 | C1721007 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.05e-04 | 112 | 122 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | KRT5 ABCA4 MAGEE1 APOL1 TTC3 WNK1 ADHFE1 KRT76 EFEMP1 OTOF NECTIN2 SPEN PCDH8 VPS13B | 1.46e-04 | 1074 | 122 | 14 | C0006142 |
| Disease | Pachyonychia Congenita | 1.68e-04 | 5 | 122 | 2 | C0265334 | |
| Disease | hemorrhoid | 3.72e-04 | 147 | 122 | 5 | EFO_0009552 | |
| Disease | glaucoma | 4.60e-04 | 154 | 122 | 5 | MONDO_0005041 | |
| Disease | common bile duct neoplasm (is_marker_for) | 4.67e-04 | 8 | 122 | 2 | DOID:4608 (is_marker_for) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.35e-04 | 243 | 122 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | Pancreatic carcinoma, familial | 5.99e-04 | 9 | 122 | 2 | C2931038 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 6.47e-04 | 166 | 122 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | cerebral amyloid deposition measurement | 6.62e-04 | 95 | 122 | 4 | EFO_0007707 | |
| Disease | dry eye syndrome (is_marker_for) | 7.47e-04 | 10 | 122 | 2 | DOID:10140 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 7.47e-04 | 10 | 122 | 2 | DOID:11204 (is_marker_for) | |
| Disease | Pancreatic Neoplasm | 8.03e-04 | 100 | 122 | 4 | C0030297 | |
| Disease | cholesteryl ester 20:4 measurement | 8.07e-04 | 44 | 122 | 3 | EFO_0010348 | |
| Disease | pancreatic cancer (is_marker_for) | 8.34e-04 | 101 | 122 | 4 | DOID:1793 (is_marker_for) | |
| Disease | Malignant neoplasm of pancreas | 8.65e-04 | 102 | 122 | 4 | C0346647 | |
| Disease | nucleus accumbens volume change measurement | 9.10e-04 | 11 | 122 | 2 | EFO_0021493 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.18e-03 | 111 | 122 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.28e-03 | 13 | 122 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.36e-03 | 291 | 122 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | unipolar depression, anxiety | 1.49e-03 | 14 | 122 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | Keratoderma, Palmoplantar | 1.96e-03 | 16 | 122 | 2 | C4551675 | |
| Disease | coronary thrombosis, GM11992 | 1.96e-03 | 16 | 122 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | uterine prolapse | 1.96e-03 | 16 | 122 | 2 | EFO_1001864 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.08e-03 | 61 | 122 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Tinnitus | 2.12e-03 | 130 | 122 | 4 | HP_0000360 | |
| Disease | otitis media (biomarker_via_orthology) | 2.21e-03 | 17 | 122 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.25e-03 | 220 | 122 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | fatty acid measurement | 2.29e-03 | 436 | 122 | 7 | EFO_0005110 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.39e-03 | 64 | 122 | 3 | DOID:4947 (is_marker_for) | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.43e-03 | 224 | 122 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | Tourette syndrome, schizophrenia | 2.48e-03 | 18 | 122 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.68e-03 | 229 | 122 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.96e-03 | 69 | 122 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | MYO9B LIN54 SUN1 FREM3 WNK1 RBM23 F8 SLC12A2 PTPRH NFRKB APOL3 LSM14A MUC4 | 3.85e-03 | 1347 | 122 | 13 | EFO_0005192 |
| Disease | visceral adipose tissue measurement | 3.93e-03 | 481 | 122 | 7 | EFO_0004765 | |
| Disease | coronary artery disease | DSCAM DNAH10 MYO9B CDKN2AIP INO80 FAM83B MUC1 SAP130 PALLD ADGRL3 MRTFA PCSK9 | 3.97e-03 | 1194 | 122 | 12 | EFO_0001645 |
| Disease | lung carcinoma | 3.98e-03 | 482 | 122 | 7 | EFO_0001071 | |
| Disease | Mammary Neoplasms, Experimental | 3.98e-03 | 155 | 122 | 4 | C0024668 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 4.05e-03 | 23 | 122 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 4.05e-03 | 23 | 122 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 4.05e-03 | 23 | 122 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 4.05e-03 | 23 | 122 | 2 | C0014556 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGDTTVTSGDATVAG | 1986 | P78363 | |
| LSTVNSGTGVALTDT | 1726 | Q8IZF6 | |
| VSSSQSFVISGGGST | 1056 | P41180 | |
| TESSIGSGKTSGSRT | 1126 | Q9HAR2 | |
| SDVASIGVSTSGSQG | 771 | Q96L96 | |
| VTIDGVTYGSGTASS | 546 | Q8WYQ5 | |
| TTTVSTTAAGTGEQR | 2351 | Q12830 | |
| TTAGNVISVIGSTET | 471 | Q9HBD1 | |
| RGTVAQQVTGSSGTV | 186 | O75771 | |
| GNETSGSSTIGETSK | 46 | Q86U06 | |
| DQLTNTSGTVIGVTS | 336 | Q8TDF5 | |
| GVSTITATSLGVNNS | 31 | O75943 | |
| DVGGSVGSASSVKST | 66 | Q5HYI8 | |
| ASITGSVSDTVNGIS | 1401 | Q9ULG1 | |
| ISVVSNVTSTSGSSG | 506 | Q01546 | |
| SGSSSGTIVTLTISG | 81 | A0A075B6K0 | |
| GQTGSVGTSVASAEQ | 171 | Q7LBR1 | |
| GTTGVTTLGTVTGTV | 876 | P51610 | |
| SSGQESAGSAVVATV | 1556 | P51610 | |
| SGSSSGTTVTLTISG | 81 | P01717 | |
| TGGTTGDTHVSLSTS | 3351 | Q8WXI7 | |
| TGTITEVSSTGVNSS | 5216 | Q8WXI7 | |
| VETTSSGHGSQSSVL | 6891 | Q8WXI7 | |
| VTGTVSQKTSPSGET | 231 | Q99102 | |
| SGSEGISTSGETTRF | 816 | Q99102 | |
| IGTEGGKNASTSATS | 171 | Q9ULC0 | |
| SGHEQTTQTGSRTTG | 1556 | Q5D862 | |
| GSSGRQVTITGSAAS | 321 | Q15365 | |
| SVGGGSSTIKYTTTS | 541 | P48668 | |
| GHIVVTSASSTSVTG | 91 | Q9H2X6 | |
| TSASSTSVTGQVLGG | 96 | Q9H2X6 | |
| TISESGVIGSTLNST | 286 | Q6MZP7 | |
| STVQTITVGGVSTSQ | 321 | Q6MZP7 | |
| TSVQPTAGEGSSTSV | 306 | Q9HCI5 | |
| TSVGTGNFSSSVSKV | 121 | Q5T3J3 | |
| SVASGSGTVHTSAVS | 1116 | Q6P4R8 | |
| QGTASGSSKAVSTVV | 1271 | Q6P4R8 | |
| SVGGGSSTIKYTTTS | 541 | P02538 | |
| VGVDVATGFSQSTST | 301 | Q4VC12 | |
| GVSTATISGSSVTSN | 56 | Q5SSG8 | |
| TISGSSVTSNGVSIV | 61 | Q5SSG8 | |
| ISVVTSSVSSGYGSG | 491 | P13647 | |
| SSAVSLVTVVGGTTV | 3106 | Q5SZK8 | |
| SAVSISVVSGSTSTG | 456 | P19013 | |
| TVLTVVTGSGHASST | 16 | P15941 | |
| SSVSSQVTTAGSGKA | 216 | Q9NXV6 | |
| AIAAGTTTTAIGTST | 96 | Q9Y6W6 | |
| GEAITSAAIGTSSVA | 901 | Q5VYK3 | |
| TGSSNSTIIGSQGSE | 561 | Q5T0W9 | |
| VSTTGSTSEGAVTAV | 661 | Q8NBP7 | |
| SGSSLDAGSRVTVTV | 956 | P51805 | |
| VTTKSGGRGTSTVSF | 76 | Q96KP1 | |
| NVTVSDGTFTTTAGV | 3601 | Q9NYQ8 | |
| VSVSVSTSHTTISGG | 501 | P04264 | |
| SVGGGSSTIKYTTTS | 541 | P04259 | |
| KTVEGNQTSSSGGSV | 286 | Q7Z5P9 | |
| GSETTRLSVIGSGTT | 2386 | Q7Z5P9 | |
| LTGTFGQSATVTGTS | 2436 | Q7Z5P9 | |
| VTGTSSNSAGVTTPE | 2446 | Q7Z5P9 | |
| SGGVTVTSGQSARVT | 2641 | Q7Z5P9 | |
| SAGVTVTSGQSVRKT | 2731 | Q7Z5P9 | |
| VTSGQSVRKTGTTGA | 2736 | Q7Z5P9 | |
| SGGETETTGQSAVKS | 2791 | Q7Z5P9 | |
| ETTGQSAVKSGTTES | 2796 | Q7Z5P9 | |
| TGVETTAKTTSGGLS | 2991 | Q7Z5P9 | |
| PTVTQTTGSSAAVSG | 3171 | Q7Z5P9 | |
| TTGSSAAVSGTTVQS | 3176 | Q7Z5P9 | |
| AAVSGTTVQSLTVSG | 3181 | Q7Z5P9 | |
| SGQTEITGSSVKESG | 3201 | Q7Z5P9 | |
| TSGQSAGVAGTTTLS | 3456 | Q7Z5P9 | |
| TTGSSAGVAGTTRLS | 3516 | Q7Z5P9 | |
| TTVSAGVTGTTGLSA | 3806 | Q7Z5P9 | |
| GVTETTGQSAKVTGT | 3891 | Q7Z5P9 | |
| TGQSAKVTGTTGQSV | 3896 | Q7Z5P9 | |
| KVTGTTGQSVGVTGT | 3901 | Q7Z5P9 | |
| ITGTTTISAGVTGTS | 3981 | Q7Z5P9 | |
| TISAGVTGTSGLSAE | 3986 | Q7Z5P9 | |
| VTGTSGLSAEATGIT | 3991 | Q7Z5P9 | |
| VTGTTGLSTEVTGTT | 4061 | Q7Z5P9 | |
| SSAVVTGTTGLSAGV | 4176 | Q7Z5P9 | |
| TGTTQLSAVVTGITG | 4261 | Q7Z5P9 | |
| TGTTGQSAEVTGTTE | 4331 | Q7Z5P9 | |
| SAGVTGTIGSSAVVT | 4486 | Q7Z5P9 | |
| SAGVTETIGSSAGVT | 4636 | Q7Z5P9 | |
| SARVTESTGLSAGVT | 4686 | Q7Z5P9 | |
| SAGVTESTGLSAGVT | 4756 | Q7Z5P9 | |
| SAGVTGTIRSSAVVT | 4766 | Q7Z5P9 | |
| SAEVTGTTGLSAGVT | 4876 | Q7Z5P9 | |
| SAGVTETIGSSAGVT | 4886 | Q7Z5P9 | |
| SARVTESTGLSAGVT | 4956 | Q7Z5P9 | |
| SAGVTGTIGSSAVVT | 4966 | Q7Z5P9 | |
| SAGVTGTIGSSAVVT | 5026 | Q7Z5P9 | |
| SAVVTGTTGLSAGIT | 5036 | Q7Z5P9 | |
| GTTGLSAGVTETTGQ | 5081 | Q7Z5P9 | |
| SAGVTETTGQSAGVT | 5086 | Q7Z5P9 | |
| SGGVTGTSVLSVEVT | 5156 | Q7Z5P9 | |
| SAGVTGTIRSSAVVT | 5286 | Q7Z5P9 | |
| SAVVTETTGLSAGVT | 5296 | Q7Z5P9 | |
| SARVTESTGLSAGVT | 5346 | Q7Z5P9 | |
| SAGVTGTIGSSAVVT | 5356 | Q7Z5P9 | |
| GATGLSAEVTRTTGS | 5391 | Q7Z5P9 | |
| SAEVTRTTGSLAGVT | 5396 | Q7Z5P9 | |
| SAEVTGTTGSSAGVT | 5466 | Q7Z5P9 | |
| SAEVTGTTGLSTGVT | 5536 | Q7Z5P9 | |
| SAGVTGTTTVSAGVT | 5566 | Q7Z5P9 | |
| SAGVTETTGLSAGVT | 5596 | Q7Z5P9 | |
| SAGVTGSTVLSAGVT | 5646 | Q7Z5P9 | |
| GSTVLSAGVTATTGQ | 5651 | Q7Z5P9 | |
| SAGVTATTGQSVGVT | 5656 | Q7Z5P9 | |
| SAGVTGTTTVSAGVT | 5706 | Q7Z5P9 | |
| SAGVTGTTGLSAEAT | 5716 | Q7Z5P9 | |
| SAGVTETIGSSAGVT | 5756 | Q7Z5P9 | |
| SAGVKGTTGQSAEVT | 5826 | Q7Z5P9 | |
| SAEVTGATGQSVGVT | 5836 | Q7Z5P9 | |
| TTGSSAEVTGITGLS | 6051 | Q7Z5P9 | |
| TTTGTTGVTTGTTLA | 6156 | Q7Z5P9 | |
| NTGITGVGSETSIET | 6226 | Q7Z5P9 | |
| GVGSETSIETGISNT | 6231 | Q7Z5P9 | |
| TSIETGISNTATTGV | 6236 | Q7Z5P9 | |
| TEATGSTRGVRTTGS | 6281 | Q7Z5P9 | |
| EATTFLGVSGTTSVG | 6426 | Q7Z5P9 | |
| GSRGSIGTESTVETT | 6486 | Q7Z5P9 | |
| TTNIGRATGATTSIV | 6796 | Q7Z5P9 | |
| GTTIISENSTTAGIT | 6931 | Q7Z5P9 | |
| SENSTTAGITAATGK | 6936 | Q7Z5P9 | |
| TTTKTTTSLGGSGTT | 6986 | Q7Z5P9 | |
| ATTSVGESGKTGAET | 7036 | Q7Z5P9 | |
| GVTTTTKTTTSLGGS | 7101 | Q7Z5P9 | |
| TEATTSTKGTGTSGT | 7376 | Q7Z5P9 | |
| TGVRTTSKTTTSLGG | 7601 | Q7Z5P9 | |
| TSKTTTSLGGTGTTR | 7606 | Q7Z5P9 | |
| TGTTRTEIKSGATTG | 7616 | Q7Z5P9 | |
| TTTFLGGSSTTGAEI | 7721 | Q7Z5P9 | |
| TGTTTGASDDQVTGS | 7821 | Q7Z5P9 | |
| GASDDQVTGSKTGTT | 7826 | Q7Z5P9 | |
| QVTGSKTGTTGVALS | 7831 | Q7Z5P9 | |
| TTVVGQKTGATTRGS | 7866 | Q7Z5P9 | |
| TEAGSKIVTTGITTG | 7971 | Q7Z5P9 | |
| GSFNTKATTSTDVGV | 7991 | Q7Z5P9 | |
| KATTSTDVGVATGVG | 7996 | Q7Z5P9 | |
| GVTSSQEGTTVVSSG | 8056 | Q7Z5P9 | |
| NTFVGTGDTTSTGSE | 1001 | Q08174 | |
| TTTATVSFVVTAGGG | 701 | O95206 | |
| GESAGGTSVSSLVVS | 226 | O00748 | |
| GLSVSEVGTQTSITT | 401 | Q9H4H8 | |
| GECTSQVTISSVGGS | 426 | Q8N1N4 | |
| AGSVKTSTTGVATTQ | 1571 | Q8WWI1 | |
| VGVAGSSLTSFGTET | 136 | Q8ND56 | |
| AQSSGSVGSSGISSI | 151 | Q96CW5 | |
| REVGSLGTSATNSVT | 1476 | P00451 | |
| VVRSAATSGAGSTTS | 1841 | Q7Z6Z7 | |
| GFGINSVSSSSVSTT | 421 | A6NF01 | |
| TIGSSSPKTGVTTAV | 396 | Q8WX93 | |
| VTSAKTGSFGVTAVT | 576 | P16070 | |
| IFSTSASRVGGTTGT | 226 | Q5JPI9 | |
| ASCGSGVVTTVTVSG | 951 | Q9BTC0 | |
| TGGNTTGISDVTVSY | 21 | P08908 | |
| ISNVVSSSTGAASGI | 186 | O95236 | |
| GTTIANVVSGSLSIS | 171 | O14791 | |
| SVGSTAGTISGEETS | 1161 | Q5VV63 | |
| KTSAGISSGVTSGDS | 1491 | Q9NSI6 | |
| SSNGTSDVITGSIQV | 536 | P13612 | |
| VGGTAATAAGTSTIS | 3306 | Q03164 | |
| RNTSVGSTSTGVESI | 236 | Q5T8I3 | |
| VIFVGESGTSKTATT | 2451 | Q8IVF4 | |
| AAVTAVGTGLVTSST | 1046 | Q7Z5N4 | |
| VGTGLVTSSTISSGV | 1051 | Q7Z5N4 | |
| TISITATSASIGAAG | 396 | P43005 | |
| SVTISCTGTSSDVGG | 36 | P01706 | |
| NGGSSSHSTGEVVVT | 1256 | Q9HC10 | |
| SITISCTGTSSDVGG | 36 | P01704 | |
| TTSGTGSETTGVAIF | 186 | Q8IWW8 | |
| GSKSGNTTTLTITGA | 81 | A0A0A0MS00 | |
| TGIGSTSAGLTVTAV | 376 | Q9NXL9 | |
| SVGSQVSLSCSVTGT | 326 | O60469 | |
| AEGTSGATTGVVAAS | 91 | Q12805 | |
| QGSATGTISSTVLFS | 1926 | P0C091 | |
| QSVGGQTLTVFTESS | 86 | P13984 | |
| SSVSQVSGGSAEGIS | 231 | Q9HCJ0 | |
| SSSGTSILTGSAIQV | 986 | A6NHR9 | |
| FGIVTSSAGTGTTED | 181 | P82979 | |
| SGSSSGTTVTLTISG | 81 | P01718 | |
| SVTISCTGTSSDVGG | 36 | P01709 | |
| TGSDTGSTVTLQTSV | 6 | P48380 | |
| GSLAVTTVGATTAGS | 1801 | Q8NFP9 | |
| IVGTISLSSESQASG | 1861 | Q96Q15 | |
| ISSQTVSGSVGTTQT | 656 | Q8IVL1 | |
| VSGSVGTTQTTGSNT | 661 | Q8IVL1 | |
| TVVVGTSGDTGSAAI | 136 | Q86YJ6 | |
| TAGTTVGKGVTTVTL | 4131 | O75592 | |
| QVSVLATASSSASGG | 41 | Q8IYB8 | |
| VASSGVVKFGSTGST | 436 | Q969V6 | |
| TETSGQIQGVAVTSS | 781 | Q8N5C6 | |
| TVGGVFITTAGSTSN | 341 | Q14186 | |
| QGKTSISTVGTSTSA | 2916 | Q8N2C7 | |
| TTQSVEGATGSAVKS | 631 | Q14157 | |
| VTAASGGVTATTGTV | 2746 | Q96T58 | |
| LSTIIGFGSGSNTST | 1331 | Q12816 | |
| TTITGLSTSAIATNG | 331 | P55011 | |
| SSQTVGLASVGTQTI | 1131 | O94964 | |
| SAITAQTGVGVASTV | 526 | Q9H0E3 | |
| VGSGTTSVTSNNEII | 1036 | P53804 | |
| ETSVVGSSSISAGSL | 1541 | Q92576 | |
| TTGGIAVGASSSKTN | 436 | O94876 | |
| IGIQGTITSSTASGD | 206 | Q53EL9 | |
| GTTVASGVTARSASG | 176 | Q4KMP7 | |
| TSASGSKTTVISAVG | 286 | Q9UHR5 | |
| AVLSTASLGSSQGSV | 1536 | P78527 | |
| TSAVFTVGDNVVSGS | 371 | Q9Y2I8 | |
| VTLEQTTSNIGGTSG | 1306 | Q7Z7G8 | |
| NVGNVVSLGSAVSTS | 261 | Q63HK3 | |
| GEGAITSSAITTVAA | 636 | Q8N1G0 | |
| VTSSGVSHGGTVSLQ | 111 | O94901 | |
| SGVSLKVVNSTTGTG | 1061 | P35442 | |
| SQQAAGSTTVGATLT | 1476 | Q9H4A3 | |
| GGTTETRNTTATNVT | 71 | Q9HD43 | |
| SSEGTSGSGSVSIRK | 321 | Q9UPU7 | |
| FSVSSLAEGSVTSVG | 576 | P13010 | |
| VVGSAVGSGSITSNI | 206 | Q9Y5A9 | |
| VGSGSITSNIVASNS | 211 | Q9Y5A9 | |
| TSGKQLTTGSVVQGT | 871 | Q9ULM3 | |
| VVQGTLGVSTSSAQG | 881 | Q9ULM3 | |
| TTSGSTAAVVTTQGS | 131 | P22415 | |
| GSTVNTSIGGNTTSA | 166 | Q9UKN1 | |
| VISGESGSGKTQSTN | 236 | B2RTY4 | |
| VISGESGSGKTQSTN | 236 | Q13459 | |
| ETQVSGTLAGTVTVT | 206 | Q92692 |